The two sides signed the protocol on the sidelines of the Global Congress on Population, Health, and Development 2023.
Dr. Hossam Abdel-Ghaffar, the official spokesperson for the Ministry of Health and Population said the protocol is designed to bolster the government's efforts in reducing genetic diseases through organising awareness campaigns on social media.
Furthermore, an extensive training programme is being developed under the guidance of the Ministry of Health and Population for medical teams working in centres specialising in the diagnosis and treatment of hereditary diseases, as well as neonatal critical care departments nationwide. The primary goal is to refine their skills and bolster their scientific knowledge, thereby enhancing their ability to provide diagnostic and treatment services for hereditary diseases.
Dr. Ahmed Hegazy, General Manager of Sanofi Specialty Care, said "As a leading healthcare company with over 60 years of presence in the Egyptian market, our mission is to cater to the needs of patients. Sanofi's commitment extends beyond producing high-quality medicines; we are dedicated to supporting health authorities, physicians, and patients to achieve more accurate diagnoses and provide improved healthcare, especially for rare diseases.”
The cooperation protocol was signed by Dr. Wael Abdel-Razek, representing the Ministry of Health and Population, and Dr. Hegazy, representing Sanofi.